Berlin-based cardiovascular medical devices manufacturer, BIOTRONIK revealed that it has received the CE approval mark for its Ilesto 7 implantable cardioverter-defibrillator/cardiac resynchronization therapy defibrillator (ICD/CRT-D).
The Illesto 7 makes use of ProMRI to access potentially life-saving MR scans and also provides the greatest longevity available for such devices, up to 11.5 years for the single chamber ICD and 7.5 years for the CRT-D device.
Doctors across Europe are currently performing implants of the first Ilesto 7 second-generation ProMRI devices with the patients also able to take advantage of BIOTRONIK's in-house remote monitoring system, Home Monitoring.
Says Dr Paul Erne from Lucerne Cantonal Hospital (LUKS), Lucerne, Switzerland, who performed one of the first implants of Ilesto 7, "The Ilesto 7 series, as well as many other BIOTRONIK devices, boasts ProMRI capability and BIOTRONIK's Home Monitoring® technology. With this, we have the opportunity to offer our patients the most advanced and reliable ICD and CRT-D therapy, an enhanced quality of life, and an opportunity to live as normal a life as possible."